Life Science Leader Magazine Supplements

CMO Leadership Awards 2012

The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.

Issue link: https://lifescienceleadermag.epubxp.com/i/85321

Contents of this Issue

Navigation

Page 34 of 59

Akorn Inc. Lake Forest, IL www.akorn.com (800) 932 5676 DRUG TYPE: Pharmaceuticals Manufacturing locations: Decatur, IL, Paonta Sahib, HP (site with available capacity), India, Somerset, NJ Contact: Sumeet Dagar, Ph.D. sumeet.dagar@akorn.com DRUG LIFE CYCLE STAGES: Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, controlled substances, creams & ointments, cytotoxic & high-potency compounds, generics, injectables, liquids, lyophilized products, ophthalmics, oral powders, OTC, parenterals (small volume), peptides, powders (sterile), solutions & suspensions, and sterile. DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – clinical (phase 2 and phase 3) Formulated Drug Production – dosage form development, dosage form production, and packaging SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, high-potency compounds, injectables, parenterals (small volume), powders (sterile), solid dose, sterile, and sustained release. Alkermes Westmeath, Ireland www.alkermes.com/contract 353 906495000 Manufacturing locations: Ireland and United States Contact: Fidelma Callanan fidelma.callanan@alkermes.com "Alkermes Contract Pharma Services are honoured to be recognized by our peers through this CMO Leadership Award. We have a proud history of quality with multiple regulatory authorities including the EMA and U.S. FDA, across our global sites. We strive to have the highest regulatory and quality standards, exemplified by our culture of 'Building Quality' in every- thing we do for our partners." — James Botkin, SVP of operations Almac Group Craigavon, Northern Ireland www.almacgroup.com 44(0)28 38332200 DRUG TYPE: Pharmaceuticals Manufacturing locations: Craigavon, Northern Ireland, Pennsylvania, U.S.A., and North Carolina, U.S.A. Contact: Kerry Lyle kerry.lyle@almacgroup.com DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Capsules, controlled substances, cytotoxic & high-potency compounds, generics, non-sterile, peptides, powders (non-sterile), proteins, solid dose, and sustained release. SERVICES OFFERED: Generics and peptides. DRUG TYPE: Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Drug Substance Production – primary process development and drug substance production AmbioPharm,Inc. North Augusta, SC www.ambiopharm.com (415) 921-3593 Manufacturing locations: North Augusta, SC and Shanghai, PRC Contact: Jim Hampton sales@ambiopharm.com "It is extremely encouraging that our customers regard Almac so highly in quality, innovation, productivity, regulatory, and reliability which is how we strive to be perceived through our core values and our overall aim of "partnering to advance human health". Working with all the leaders in the pharmaceutical and biotech sectors, our aim is to establish long-term partnerships and the fact that over 95% of our business is repeat is genuine evidence of our success." — Alan Armstrong, CEO "AmbioPharm, Inc. (APi) is a full-service peptide manufacturing company headquartered at our cGMP peptide manufacturing facility in North Augusta, SC. In our cGMP manufacturing facility in Shanghai, China, we manufacture peptides on very large scales, provide pilot manufacturing and process development, and manufacture raw materials, building blocks, and custom peptides." — Chris Bai, president and CEO The CMO Leadership Awards 2012 35 DRUG LIFE CYCLE STAGES

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO Leadership Awards 2012